Finzati - Logo
AVNT logo

Avient Corporation

AVNT • Chemicals - Specialty
$43.40
▲ +0.49 (+1.14%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$3.91B
Growth
1.1%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 2.13Consistent free cash flow · 5/5Manageable debt level · 0.81Healthy liquidity · 1.66Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:48 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$43.40
Change1.14%
Market Cap$3.91B
52W Range27.48 - 44.85
Beta1.28
Gross Margin32.46%
Oper. Margin6.24%
Profit Margin2.51%
Debt/Eq0.81
Current Ratio1.66
Quick Ratio1.22
Revenue 5Y1.06%

Investment DNA

How strong this company looks for long-term investors

59
out of 100
Business Quality
Margins, moat, returns
29/100
Financial Strength
Debt, cash, stability
65/100
Growth Potential
Revenue and expansion
54/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Positive free cash flow · 2.13Consistent free cash flow · 5/5Manageable debt level · 0.81Healthy liquidity · 1.66Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$43.00
Mean
$47.67
Median
$45.50
High
$56.00

Company Overview

IPO: 9/13/1999
Industry: Chemicals - Specialty
P/B i: 1.20
Debt / Equity i: 0.81
Operating Margin: 6.24%
Net Margin: 2.51%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.81
Current Ratio: 1.66
Quick Ratio: 1.22
Status: Good

Insider Transactions

Recent executive and insider activity

ABERNATHY ROBERT E
Transaction: 06/30/2026
BUY
Change
+1,049
Price
Not reported
Filing
07/02/2026
Type
BUY
LIN SANDRA BEACH
Transaction: 06/30/2026
BUY
Change
+1,049
Price
Not reported
Filing
07/02/2026
Type
BUY
FEARON RICHARD H
Transaction: 06/30/2026
BUY
Change
+1,049
Price
Not reported
Filing
07/02/2026
Type
BUY